Close
Clinical Trials
S2015 Melanoma Margins Trial (MelMarT): A Phase III, Multi-Centre, Multi-National Randomised Control Trial Investigating 1cm v 2cm Wide Excision Margins for Primary Cutaneous Melanoma (CTMS# 23-0072)
Cancer Type
Melanoma, skin
ClinicalTrials.gov Identifier
ClinicalTrials.gov registration not required
Principal Investigator
Federico Tozzi MD
For more information about this study
View DetailsAbout This Study
The primary objective of the trial is to assess whether there is no difference in disease-free survival for patients treated with a 1cm excision margin when compared to a 2cm margin for stage II primary melanomas (AJCC 8th edition; pT2b-pT4b).